Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesTransplantation ConditioningAnemia, AplasticHematopoietic Stem Cell TransplantationLiver TransplantationLeukemiaTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicCyclophosphamideKidney TransplantationBone Marrow DiseasesMice, Inbred C57BLHematopoiesisRecurrenceImmune ToleranceRadiation ChimeraCombined Modality TherapyGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsTime FactorsTreatment OutcomeHematologic NeoplasmsDrug ToleranceRemission InductionTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingGraft vs Host ReactionImmunosuppressionBone Marrow NeoplasmsHeart TransplantationLiving DonorsLymphocyte DepletionLeukemia, MyeloidLeukocyte TransfusionStem Cell TransplantationAcute DiseaseT-LymphocytesLymphoma, Non-HodgkinChimeraHLA AntigensSevere Combined ImmunodeficiencySurvival AnalysisRetrospective StudiesColony-Forming Units AssayTransplantation ToleranceMyelodysplastic SyndromesLung TransplantationCyclosporineActuarial AnalysisHematologic DiseasesLymphocyte TransfusionBlood DonorsBone DensityOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCell DifferentiationSpleenFollow-Up StudiesCarmustineGraft vs Tumor EffectMice, Inbred BALB CPancytopeniaSurvival RateCytomegalovirus InfectionsGraft vs Leukemia EffectLeukocyte CountCytarabineFlow CytometryGranulocyte Colony-Stimulating FactorBone ResorptionCells, CulturedMelphalanDisease-Free SurvivalEtoposideLymphomaMultiple MyelomaMice, KnockoutSkin TransplantationFatal OutcomeAntigens, CD34